![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Synairgen Plc | LSE:SNG | London | Ordinary Share | GB00B0381Z20 | ORD 1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 4.675 | 4.36 | 4.99 | - | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | 0 | -17.65M | -0.0876 | -0.53 | 9.41M |
Date | Subject | Author | Discuss |
---|---|---|---|
15/10/2020 22:16 | Haha you guys are really trying hard tonight. It was subcutaneous (intravenous) that failed. This has nothing to do with our patented inhaled menthod and is actually a massive positive for Synairgen as we become one of very few therapeutics globally with outstanding phase 2 results. I believe Synairgen will imminently be authorized for emergency use. | oranolio | |
15/10/2020 22:08 | Just reading the FT WHO article, isn't this bad for us too? It mentions Interferon didn't work either. | ![]() 4noddy | |
15/10/2020 21:33 | Nobby? Vitec? Waterloo? | ![]() festario | |
15/10/2020 21:27 | I wont discount Numis valuation. You may see the other Broker matching it. Imho...resistance at 3..4...5...quids as we move towards December and the flu season. Sng is progressing quite nicely and has to adhere to global regulations. Is it not great news that the product will be trialled in 20 countries? Plus the Clinigen deal might be more important than we realise....onwards and upwards.. | allin | |
15/10/2020 21:16 | Oranolio, I was hoping for a sensible person to address my point. Looks like I'm still waiting.I have a holding of 96k shares, only 20k of which I try to trade, in order to earn a few copper coins.SNG is my biggest shareholding.Please don't resort to the old VRS style of debate, which revolves around blaming any genuine issue on fictitious shorters, or encourages the enquirer to sell up and eff off. | ![]() festario |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions